US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

710.58

+24.843.62%

Number of Gainers:84

Number of Losers:59

Number of Flat:11

PE:- -

High:710.84

Open:685.68

Low:683.13

Close:685.75

Volume:329.26M

Turnover:10.37B

Market Cap:495.36B

Float Cap:376.11B

Loading ...

Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)

Absci Falls After Q2 Revenue Misses Estimates

Coinbase Sets September 9, 2026, for Deribit Infrastructure Migration to Unify Derivatives Ecosystem

Global-e Raises 2026 Outlook As E-Commerce Volume Jumps 44%

Benzinga Earnings

Nexxen International Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Similarweb Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary

Riskified Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary

Unicycive Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Global-E Online Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary

Acumen Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Digital Brands Group Achieves Major Financial Turnaround, Forecasts Positive Cash Flow Starting September

THOMSON REUTERS

LiveWorld Q2 Net Loss Widens on Higher Operating Costs

Flywire Expands Trustly Partnership to Deliver Open Banking Payments Across the U.S. and Canada

THOMSON REUTERS

Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents

TScan Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)

Century Therapeutics Reports Q2 Results, Pipeline Advancements

Acurx Pharmaceuticals Inc Expected to Post a Loss of 38 Cents a Share - Earnings Preview

Aprea Therapeutics Announces Second Quarter 2026 Financial Results

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/BK4539/news?page=47"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":710.5842,"timestamp":1787687999999,"preClose":685.7458,"halted":0,"volume":329259151,"delay":0,"changeRate":0.036221,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":24.83844,"latestTime":"08-25 16:00:00 EDT","open":685.6775,"high":710.84143,"low":683.1322,"amount":10370226198.826471,"amplitude":0.040407,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.436531,"peRate":156.391987,"turnoverRate":0.025545,"increases":84,"decrements":59,"flats":8,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":710.84143,"amplitude":0.040407,"preClose":685.7458,"low":683.1322,"pbRate":"5.436531","latestPrice":710.5842,"volume":329259151,"delay":0,"open":685.6775,"prevYearClose":881.5255,"prevWeekClose":700.9769,"prevMonthClose":673.0273,"prevQuarterClose":742.922,"fiveDayClose":655.4622,"twentyDayClose":704.4272,"sixtyDayClose":779.4826,"secType":"PLATE","market":"US","turnoverRate":0.025545,"peRate":156.391987,"marketCap":495359143396.625,"floatMarketCap":376108388528.9375,"timestamp":1787687999999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":84,"down":59,"flat":11},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:47,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2658490602","title":"Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658490602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658490602?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:10","pubTimestamp":1786547413,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on TScan Therapeutics (TCRX), Eli Lilly & Co (LLY) and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tscan-therapeutics-tcrx-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tscan-therapeutics-tcrx-eli-lilly-co-lly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU1974910355.USD","LU0354030438.USD","LU0289739699.SGD","MHIP","LU2471134879.HKD","AGNG","LU2471134796.USD","LU0943347566.SGD","IXJ","LU1804176565.USD","LU2471134523.USD","LU0006306889.USD","LU0889565916.HKD","LU0158827781.USD","LU0225283273.USD","LU2111349929.HKD","LU2108987350.USD","LU2456880835.USD","LU0109391861.USD","LU2089283258.USD","LU2750360641.GBP","SG9999014906.USD","LU0133085943.USD","SG9999017495.SGD","LU1291159041.SGD","LU2271345857.HKD","LU2360106947.USD","LU1868836757.USD","MEDX","LU0316494557.USD","THNR","SG9999015952.SGD","LU1551013425.SGD","LU0345770993.USD","IE0005OL40V9.USD","OZEM","SGXZ57979304.SGD","LU1629891620.HKD","IE00B1XK9C88.USD","HRTS","LU2236285917.USD","LU2106854487.HKD","LU0323591593.USD","LU1720051108.HKD","LU0471298777.SGD","LU0820562030.AUD","IE00BJJMRX11.SGD","LU0122379950.USD","LU2237443622.USD","LU2756315664.SGD","IE00BN29S564.USD","IE00BJJMRY28.SGD","LU1868836914.USD","SG9999014880.SGD","LU2089284900.SGD","LU0823434583.USD","GDOC","FHLC","LU1366192091.USD","IE00BKDWB100.SGD","SG9999018857.SGD","BK4534","ILDR","BK4599","LU0096364046.USD","LU2265009873.SGD","SG9999015978.USD","LU0198837287.USD","FTXH","LLII","LU1023059063.AUD","LU0158827948.USD","LU2324357040.USD","LU0058720904.USD","LU0432979614.USD","LU2491049909.HKD","SGXZ31699556.SGD","IYH","LU0174119429.USD","IE00BFSS7M15.SGD","LU2168564065.EUR","LU0820561909.HKD","LU1988902786.USD","LU1623119135.USD","LU2168563687.JPY","LU0353189763.USD","LU0109394709.USD","BK4516","LU2461242641.AUD","BK4581","IE0004445015.USD","LU2023250504.SGD","LU0471298694.HKD","LU0823434740.USD","LU1093756325.SGD","LU0823416689.USD","LU0882574139.USD","SG9999014898.SGD","BK4539","IE00B775H168.HKD","LU1145028129.USD","LU2756315318.SGD","LU0385154629.USD","IE00BFTCPJ56.SGD","LU2063271972.USD","IE0002141913.USD","LU0708995401.HKD","LU2237443382.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0094547139.USD","LU1712237335.SGD","LU2023250330.USD","LU1551013342.USD","SG9999018865.SGD","LU2089984988.USD","CANC","LU1093756168.USD","TRUH","TMED","SG9999013999.USD","LU2746668974.SGD","LLYZ","LU1280957306.USD","LU1064131342.USD","LU0079474960.USD","LU2361045086.USD","IE00B4JS1V06.HKD","IE00BJT1NW94.SGD","LU0882574055.USD","LU0683600562.USD","LU0256863811.USD","SGXZ51526630.SGD","SG9999014914.USD","IE00B4R5TH58.HKD","LU2491050071.SGD","LU0786609619.USD","LU1983299246.USD","LU0114720955.EUR","LU1868837136.USD","LU0345770308.USD","LU2112291526.USD","IE00BKPKM429.USD","LU2361044865.SGD","LU0203202063.USD","IE0004445239.USD","ELIL","LU2468319806.SGD","LU2896262040.SGD","LU0266013472.USD","LLY","LU1267930730.SGD","LU2491050154.USD","LU0672654240.SGD","LU0417517546.SGD","LU1814569148.SGD","LU1323610961.USD","LU2211815571.USD","LU2552382215.SGD","LU0354030511.USD","LU2237443978.SGD","IE00BJJMRZ35.SGD","LU0320765059.SGD","LU0203201768.USD","LU2471134952.CNY","LU1868837300.USD","LU2237438978.USD","LU2264538146.SGD","IE00BJLML261.HKD","LU2237443549.SGD","ELIS","LU2168564495.EUR","VHT","LU2602419157.SGD","LU0456855351.SGD","IE00BFSS8Q28.SGD","LU0238689110.USD","LU0106261372.USD","LU2168564222.USD","LU1035775433.USD","LU2028103732.USD","IE00B1BXHZ80.USD","LU2357305700.SGD","LU2213496289.HKD","LU2462157665.USD","LU2023251221.USD","IHE","BK4585","LU0640476718.USD","LU0964807845.USD","LU1232071149.USD","LU2087625088.SGD","LU2462591350.SGD","SG9999001176.SGD","LU1127390331.HKD","IE0009355771.USD","LU1720051017.SGD","LU1548497426.USD","LU2168564149.EUR","LU2361044949.HKD","PPH","IE00B7KXQ091.USD","MEDI","WDNA","LU1989771016.USD","TCRX","LU2746668461.USD","LU1917777945.USD","LU0061475181.USD","SGXZ81514606.USD","LU1979441026.SGD","LU2417539215.USD","LU2750360997.AUD","JDOC","BK4007","IE00BWXC8680.SGD","SG9999001176.USD","LLYX","GB00BDT5M118.USD","IE0001KFT4U8.USD","IE00B2B36J28.USD","LU0353189680.USD","PJP","LU0234572021.USD","LU2552382132.HKD","LU1057294990.SGD","LU1069344957.HKD","RXL","IE00BK4W5L77.USD","LU1868836591.USD","LU2237443895.HKD","LU0787776722.HKD","LU2237443465.HKD","LU2552382058.USD","SG9999015945.SGD","SG9999015986.USD","SGXZ99366536.SGD","BK4588","LU0210536198.USD","LU0689472784.USD","LU0320765992.SGD","LU0097036916.USD","BK4139","LU0820561818.USD","CURE","LU0466842654.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903561","title":"Absci Falls After Q2 Revenue Misses Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903561","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903561?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:03","pubTimestamp":1786543410,"startTime":"0","endTime":"0","summary":"BUZZ-Absci falls after Q2 revenue misses estimates** Shares of drug developer AbsciABSI.Ofall 1.4% to $9.3** Co posts Q2 revenue of $318,000, sharply below analysts' estimates of $1.2 mln** Reports increase in R&D expenses of $22.6 mln compared to $20.5 mln last year, primarily driven by advancement of ABSI's internal programs** Brokerage TD Cowen says revenue is expected to nearly halve due to lower collaboration and milestone payments, underscoring its reliance on partner-funded revenue** Says investors are pivoting the attention to its ABS-201 hair-loss data expected later this year- TD Cowen** Nine of 10 brokerages rate the stock \"buy\" or higher and one \"hold\"; median PT is $14- LSEG data** Including session's move, stock has more than doubled in value, YTD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL6N4490SG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4121","ABSI","BK4139","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176227264","title":"Coinbase Sets September 9, 2026, for Deribit Infrastructure Migration to Unify Derivatives Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=1176227264","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176227264?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:41","pubTimestamp":1786542102,"startTime":"0","endTime":"0","summary":"Coinbase Global, Inc. (COIN.US) has confirmed a key technical architecture adjustment scheduled for September 9, 2026, when it will fully migrate its overseas perpetual futures infrastructure to the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICOI","BITQ","BLCK","BK4600","BK4535","BK4595","BK4551","LU1861559042.SGD","COIG","BK4516","COIW","LU2360107671.USD","CONY","COII","LU1861220207.SGD","FINX","CONL","IBLC","FIAT","BK4554","LU1861558580.USD","COIA","COIO","COIN","CRPT","LU1861217088.USD","BK4539","BK4596","CONI","BK4112","BKCH","FDIG","CONX","BK4585","BK4588","COYY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658490890","title":"Global-e Raises 2026 Outlook As E-Commerce Volume Jumps 44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658490890","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658490890?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:37","pubTimestamp":1786541864,"startTime":"0","endTime":"0","summary":"Global-e (GLBE) beats Q2 estimates with $299M revenue &amp; $0.37 EPS. Full-year outlook raised as stock jumps.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/earnings/26/08/61142087/global-e-raises-2026-outlook-as-e-commerce-volume-jumps-44","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4220","BK4539","GLBE","BK4585","BK4588","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658686908","title":"Nexxen International Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658686908","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658686908?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:32","pubTimestamp":1786541548,"startTime":"0","endTime":"0","summary":"Nexxen International Ltd reports results for the quarter ended June 30 - Earnings SummaryNexxen International LtdNEXN.OQreported quarterly adjusted earnings of 23 cents per share for the quarter ended","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXN","BK4009","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908528","title":"Similarweb Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908528","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908528?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:31","pubTimestamp":1786541516,"startTime":"0","endTime":"0","summary":"Similarweb Ltd. reports results for the quarter ended June 30 - Earnings SummarySimilarweb Ltd.SMWB.Nreported quarterly adjusted earnings of 6 cents per share for the quarter ended June 30, higher tha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491D6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMWB","BK4539","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658520908","title":"Riskified Ltd Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658520908","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658520908?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:31","pubTimestamp":1786541514,"startTime":"0","endTime":"0","summary":"Riskified Ltd reports results for the quarter ended June 30 - Earnings SummaryRiskified LtdRSKD.Nreported quarterly adjusted earnings of 2 cents per share for the quarter ended June 30, identical to t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491D4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","RSKD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908540","title":"Unicycive Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908540","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908540?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:31","pubTimestamp":1786541509,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryUnicycive Therapeutics IncUNCY.OQreported a quarterly adjusted loss of 52 cents per share for the quarter end","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491D0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908546","title":"Global-E Online Ltd. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908546","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908546?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:31","pubTimestamp":1786541508,"startTime":"0","endTime":"0","summary":"Global-E Online Ltd. reports results for the quarter ended June 30 - Earnings SummaryGlobal-E Online Ltd.GLBE.OQreported quarterly adjusted earnings of 27 cents per share for the quarter ended June 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491CU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4588","BK4220","BK4122","BK4585","GLBE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658908534","title":"Acumen Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658908534","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658908534?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:30","pubTimestamp":1786541450,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings SummaryAcumen Pharmaceuticals IncABOS.OQreported a quarterly adjusted loss of 45 cents per share for the quarter end","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N4491C4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658015970","title":"Digital Brands Group Achieves Major Financial Turnaround, Forecasts Positive Cash Flow Starting September","url":"https://stock-news.laohu8.com/highlight/detail?id=2658015970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658015970?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:23","pubTimestamp":1786540988,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nFWN4491E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DBGI","BK4539","BK4094","BK4122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970424","title":"LiveWorld Q2 Net Loss Widens on Higher Operating Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970424","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970424?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:10","pubTimestamp":1786540207,"startTime":"0","endTime":"0","summary":"LiveWorld Q2 net loss widens on higher operating costsOverviewAI-powered intelligence systems firm's Q2 revenue grew 9% yr/yr, driven by healthcare segmentCompany posted Q2 net loss from operations of","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LVWD","SMWB","BK4608","BK4139","BK4023","BK4516","APRE","PHUN","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970655","title":"Flywire Expands Trustly Partnership to Deliver Open Banking Payments Across the U.S. and Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970655","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970655?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA40QJ9Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","BK4539","FLYW","BK4106","LU0757428866.USD","BK4535","BK4227"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658890890","title":"Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents","url":"https://stock-news.laohu8.com/highlight/detail?id=2658890890","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658890890?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539600,"startTime":"0","endTime":"0","summary":"-- New U.S. and international patents complement existing delivery system patents, extending global IP coverage for the FemBloc solution -- ATLANTA, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NA","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343690/0/en/femasys-strengthens-and-extends-global-patent-protection-for-fembloc-with-first-issued-blended-polymer-patents.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4082","BK4584","FEMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658023977","title":"TScan Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2658023977","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658023977?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:50","pubTimestamp":1786539041,"startTime":"0","endTime":"0","summary":"TScan Therapeutics Inc reports results for the quarter ended June 30 - Earnings SummaryTScan Therapeutics IncTCRX.OQreported a quarterly adjusted loss of 23 cents per share for the quarter ended June ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44917M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TCRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658709499","title":"Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658709499","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658709499?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:50","pubTimestamp":1786539013,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-genmab-gmab-definitive-healthcare-corp-dh-and-atai-beckley-n-v-atai-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4167","ATAI","BK4581","BK4139","BK4007","XBI","BK4585","BK4588","DH","GMAB","BK4539","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658197095","title":"Century Therapeutics Reports Q2 Results, Pipeline Advancements","url":"https://stock-news.laohu8.com/highlight/detail?id=2658197095","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658197095?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:48","pubTimestamp":1786538907,"startTime":"0","endTime":"0","summary":"An announcement from Century Therapeutics ( ($IPSC) ) is now available. Century Therapeutics reported its second-quarter 2026 results on August 12,...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-reports-q2-results-pipeline-advancements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/century-therapeutics-reports-q2-results-pipeline-advancements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","IPSC","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658777839","title":"Acurx Pharmaceuticals Inc Expected to Post a Loss of 38 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658777839","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658777839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:45","pubTimestamp":1786538706,"startTime":"0","endTime":"0","summary":"Acurx Pharmaceuticals Inc <ACXP.OQ> expected to post a loss of38cents a share - Earnings PreviewAcurx Pharmaceuticals IncACXP.OQACXP.Ois expected to  show no change in quarterly revenue when it report","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL8N44916U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086439","title":"Aprea Therapeutics Announces Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086439","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086439?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"Enrollment in the ongoing Phase 1 dose escalation ACESOT-1051 trial of oral WEE1 inhibitor APR-1051 is accelerating as dose escalation advances Aprea plans to advance APR-1051 in uterine serous carcin","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343645/0/en/aprea-therapeutics-announces-second-quarter-2026-financial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","BK4539","BK4007","BK4139","PROC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086429","title":"Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086429","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086429?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"Contrasting Science with Revolution Medicines and ErascaMELBOURNE, Australia, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutica","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343641/0/en/propanc-biopharma-highlights-differentiated-proenzyme-therapy-prp-as-a-potential-therapy-of-choice-against-ras-driven-cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861215975.USD","LU1861219969.SGD","CANC","IE00BZ199S13.USD","PTH","ON","BBH","LU1861214812.USD","RVMD","LU1854104046.USD","LU2298322129.HKD","LU1861220033.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU2357305700.SGD","IE0002141913.USD","ERAS","CHH","LU0320765992.SGD","LU1548497426.USD","LU0124384867.USD","LU1720051017.SGD","LU1983260115.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4512","BK4139","LU1720051108.HKD","IE00BFMHRM44.USD","IE00BJT1NW94.SGD","IDNA","BK4142","BK4539","LU1978683503.SGD","IE0009355771.USD","BK4585","IE00BD6J9T35.USD","BK4141","LU0109394709.USD","BK4588","LU0724618433.USD","LU0348723411.USD","BK4605","PDX","LU1854103824.USD","LU2360107325.USD","IE00B2B36J28.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":51,"pageCount":47,"totalSize":1008,"code":"91000000","status":"200"}]}}